TWD
IPSC icon

True Wealth Design’s Century Therapeutics IPSC Stock Holding History

True Wealth Design’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-266
Closed -$149 – 2801
2025
Q2 		$149 Buy
266
+211
+384% +$113 ﹤0.01% 2147
2025
Q1 		$27 Buy
+55
New +$41 ﹤0.01% 2529

Other funds holding IPSC

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

True Wealth Design's IPSC Position: Q3 2025 in Review

True Wealth Design sold out of Century Therapeutics (IPSC) in Q3 2025, closing a stake of 266 shares — an estimated $149 sold.

True Wealth Design first reported a position in IPSC in Q1 2025 and held it in 2 quarters. The position peaked at $149 in Q2 2025. 57 funds tracked by Wall St. Rank hold IPSC as of Q3 2025.

  • True Wealth Design reported no remaining Century Therapeutics position as of Q3 2025 after selling out during the quarter.
  • True Wealth Design sold 266 Century Therapeutics shares in Q3 2025, an estimated $149.
  • True Wealth Design first reported a position in Century Therapeutics in Q1 2025 and held it in 2 quarters.
  • True Wealth Design's Century Therapeutics position peaked at $149 in Q2 2025.
  • 57 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2025.

Based on True Wealth Design's 13F filing for Q3 2025, filed 21 Oct 2025.